| Bedaquiline–pretomanid–linezolid regimens for drug-resistant tuberculosis F Conradie, TR Bagdasaryan, S Borisov, P Howell, L Mikiashvili, ... New England Journal of Medicine 387 (9), 810-823, 2022 | 307 | 2022 |
| Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label … R Dawson, AH Diacon, D Everitt, C van Niekerk, PR Donald, DA Burger, ... The Lancet 385 (9979), 1738-1747, 2015 | 299 | 2015 |
| High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia N Wolter, S Tempia, C Cohen, SA Madhi, M Venter, J Moyes, S Walaza, ... The Journal of infectious diseases 210 (10), 1649-1657, 2014 | 215 | 2014 |
| Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting M Shah, E Variava, CB Holmes, A Coppin, JE Golub, J McCallum, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 52 (2), 145-151, 2009 | 197 | 2009 |
| Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind … F von Groote-Bidlingmaier, R Patientia, E Sanchez, V Balanag, E Ticona, ... The Lancet Respiratory Medicine 7 (3), 249-259, 2019 | 188 | 2019 |
| Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study W Jassat, C Cohen, S Tempia, M Masha, S Goldstein, T Kufa, ... The Lancet HIV 8 (9), e554-e567, 2021 | 184 | 2021 |
| Severe influenza-associated respiratory infection in high HIV prevalence setting, South Africa, 2009–2011 C Cohen, J Moyes, S Tempia, M Groom, S Walaza, M Pretorius, ... Emerging infectious diseases 19 (11), 1766, 2013 | 180 | 2013 |
| Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis N Ndjeka, F Conradie, K Schnippel, J Hughes, N Bantubani, H Ferreira, ... The International Journal of Tuberculosis and Lung Disease 19 (8), 979-985, 2015 | 173 | 2015 |
| Difference in mortality among individuals admitted to hospital with COVID-19 during the first and second waves in South Africa: a cohort study W Jassat, C Mudara, L Ozougwu, S Tempia, L Blumberg, MA Davies, ... The Lancet Global Health 9 (9), e1216-e1225, 2021 | 160 | 2021 |
| Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International … GR Thompson, T Le, A Chindamporn, CA Kauffman, ... The Lancet Infectious Diseases 21 (12), e364-e374, 2021 | 159 | 2021 |
| Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a … CD Tweed, R Dawson, DA Burger, A Conradie, AM Crook, CM Mendel, ... The Lancet Respiratory Medicine 7 (12), 1048-1058, 2019 | 151 | 2019 |
| Community-based targeted case finding for tuberculosis and HIV in household contacts of patients with tuberculosis in South Africa AE Shapiro, E Variava, MH Rakgokong, N Moodley, B Luke, S Salimi, ... American journal of respiratory and critical care medicine 185 (10), 1110-1116, 2012 | 146 | 2012 |
| Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020 S Tempia, S Walaza, JN Bhiman, ML McMorrow, J Moyes, T Mkhencele, ... Eurosurveillance 26 (29), 2001600, 2021 | 132 | 2021 |
| High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen N Ndjeka, K Schnippel, I Master, G Meintjes, G Maartens, R Romero, ... European Respiratory Journal 52 (6), 2018 | 127 | 2018 |
| Quantitative analysis of a urine-based assay for detection of lipoarabinomannan in patients with tuberculosis M Shah, NA Martinson, RE Chaisson, DJ Martin, E Variava, SE Dorman Journal of clinical microbiology 48 (8), 2972-2974, 2010 | 110 | 2010 |
| High prevalence of pulmonary tuberculosis but low sensitivity of symptom screening among HIV-infected pregnant women in South Africa CJ Hoffmann, E Variava, M Rakgokong, K Masonoke, M van der Watt, ... PloS one 8 (4), e62211, 2013 | 104 | 2013 |
| Mortality amongst patients with influenza-associated severe acute respiratory illness, South Africa, 2009-2013 C Cohen, J Moyes, S Tempia, M Groome, S Walaza, M Pretorius, ... PloS one 10 (3), e0118884, 2015 | 100 | 2015 |
| Epidemiology of viral-associated acute lower respiratory tract infection among children< 5 years of age in a high HIV prevalence setting, South Africa, 2009–2012 C Cohen, S Walaza, J Moyes, M Groome, S Tempia, M Pretorius, ... The Pediatric infectious disease journal 34 (1), 66-72, 2015 | 99 | 2015 |
| Dolutegravir as first-or second-line treatment for HIV-1 infection in children A Turkova, E White, HA Mujuru, AR Kekitiinwa, CM Kityo, A Violari, ... New England Journal of Medicine 385 (27), 2531-2543, 2021 | 89 | 2021 |
| Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross … NA Ismail, SV Omar, H Moultrie, Z Bhyat, F Conradie, M Enwerem, ... The Lancet Infectious Diseases 22 (4), 496-506, 2022 | 83 | 2022 |
